시장보고서
상품코드
1622427

지능형 천식 모니터링 디바이스 시장 규모, 점유율, 성장 분석 : 제품별, 최종 용도별, 지역별 - 산업 예측(2025-2032년)

Intelligent Asthma Monitoring Devices Market Size, Share, Growth Analysis, By Product (Wearable Asthma Monitoring Devices, Smart Inhalers), By End Use (Hospitals, Clinics), By Region - Industry Forecast 2025-2032

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 157 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 지능형 천식 모니터링 디바이스 시장 규모는 2023년에 6억 4,596만 달러에 달하며, 예측 기간(2025-2032년)의 CAGR은 25.6%로, 2024년 8억 1,133만 달러에서 2032년에는 50억 2,473만 달러로 성장할 전망입니다.

세계의 지능형 천식 모니터링 디바이스 시장은 대기 오염 증가, 실내 공기 오염 물질에 취약한 인구 증가, COPD 및 천식 환자의 현저한 증가로 인해 상당한 성장세를 보이고 있습니다. 이러한 성장을 가속하는 주요 요인으로는 스마트 흡입기의 순응도 강화, 환자 중심 치료로의 전환, 제약회사와 스마트 흡입기 제조업체의 제휴 등이 있습니다. 첨단 디지털 기기는 현재 사용자에게 천식 발작 가능성을 경고하고, 순응도를 효과적으로 모니터링하며, 개인용 기기로의 데이터 전송을 용이하게 하고, 투여 시간을 면밀히 기록하는 등 다양한 기능을 제공합니다. 모바일 건강 용도, 웨어러블 및 개인 모니터링 기술의 통합은 천식 관리를 개선할 수 있는 큰 잠재력을 가지고 있으며, 이러한 기술 혁신은 호흡기 질환과의 지속적인 싸움에서 중요한 요소로 자리매김하고 있습니다.

목차

서론

  • 조사의 목적
  • 조사 범위
  • 정의

조사 방법

  • 정보 조달
  • 2차 데이터와 1차 데이터 방법
  • 시장 규모 예측
  • 시장의 전제조건과 제한

개요

  • 세계 시장 전망
  • 공급과 수요 동향 분석
  • 부문별 기회 분석

시장 역학과 전망

  • 시장 개요
  • 시장 규모
  • 시장 역학
    • 촉진요인과 기회
    • 억제요인과 과제
  • Porter의 산업 분석

주요 시장 인사이트

  • 주요 성공 요인
  • 경쟁의 정도
  • 주요 투자 기회
  • 시장 에코시스템
  • 시장의 매력 지수(2024년)
  • PESTEL 분석
  • 거시경제 지표
  • 밸류체인 분석
  • 가격 분석
  • 규제 상황
  • 사례 연구
  • 기술의 진보
  • 무역 분석

지능형 천식 모니터링 디바이스 시장 규모 : 제품별

  • 시장 개요
  • 웨어러블 천식 모니터링 디바이스
  • 스마트 흡입기
  • 흡입기
  • 건조 분말 흡입기(DPI)
  • 정량 분무식 흡입기(MDI)
  • 네뷸라이저

지능형 천식 모니터링 디바이스 시장 규모 : 최종 용도별

  • 시장 개요
  • 병원
  • 클리닉
  • 가정용
  • 기타

지능형 천식 모니터링 디바이스 시장 규모

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 스페인
    • 프랑스
    • 영국
    • 이탈리아
    • 기타 유럽 지역
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 기타 라틴아메리카 지역
  • 중동 및 아프리카
    • GCC 국가
    • 남아프리카공화국
    • 기타 중동 및 아프리카

경쟁 정보

  • 상위 5사의 비교
  • 주요 기업의 시장 포지셔닝(2024년)
  • 주요 시장 기업이 채택한 전략
  • 시장의 최근 동향
  • 기업의 시장 점유율 분석(2024년)
  • 주요 기업의 기업 개요
    • 회사 개요
    • 제품 포트폴리오 분석
    • 부문별 점유율 분석
    • 매출의 전년대비 비교(2022-2024년)

주요 기업 개요

  • Adherium Limited(New Zealand)
  • AstraZeneca plc(United Kingdom)
  • Boehringer Ingelheim International GmbH(Germany)
  • Cohero Health, Inc.(United States)
  • GlaxoSmithKline plc(United Kingdom)
  • Health Care Originals, Inc.(United States)
  • Koninklijke Philips N.V.(Netherlands)
  • Teva Pharmaceutical Industries Ltd.(Israel)
  • Vectura Group plc(United Kingdom)
  • Volansys Technologies Pvt. Ltd.(India)
  • 3 M(United States)
  • AEvice Health(Singapore)
  • Respiri Limited(Australia)
  • Quvium(United States)
  • Findair(Poland)
  • Sensirion AG(Switzerland)
  • Thorasys Thoracic Medical Systems Inc.(Canada)
  • Vitalograph Ltd.(Ireland)
  • Zephyr Sleep Technologies(Canada)

결론과 권장사항

KSA 25.01.23

Global Intelligent Asthma Monitoring Devices Market size was valued at USD 645.96 million in 2023 and is poised to grow from USD 811.33 million in 2024 to USD 5024.73 million by 2032, growing at a CAGR of 25.6% during the forecast period (2025-2032).

The global market for intelligent asthma monitoring devices is experiencing significant growth due to rising air pollution, an increase in individuals vulnerable to indoor air contaminants, and a notable upsurge in COPD and asthma cases. Key factors driving this expansion include enhanced adherence to smart inhalers, a shift towards patient-centered care, and partnerships between pharmaceutical firms and smart inhaler producers. Advanced digital devices now alert users to potential asthma attacks, effectively monitor adherence, and facilitate the transmission of data to personal devices, meticulously documenting dosing times. The integration of mobile health applications, wearables, and personal monitoring technologies holds tremendous potential for improving asthma management, positioning these innovations as critical components in the ongoing battle against respiratory conditions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intelligent Asthma Monitoring Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Intelligent Asthma Monitoring Devices Market Segmental Analysis

Global Intelligent Asthma Monitoring Devices Market is segmented by product, end use and region. Based on product, the market is segmented into wearable asthma monitoring devices, smart inhalers, inhalers, dry powdered inhalers (DPI's), metered dose inhalers (MDI's) and nebulizers. Based on end use, the market is segmented into hospitals, clinics, home use and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Intelligent Asthma Monitoring Devices Market

The global market for intelligent asthma monitoring devices is experiencing significant growth, primarily driven by the rising prevalence of asthma and the growing adoption of smart inhalers. Increasing levels of pollution worldwide contribute to a higher incidence of asthma, thereby driving demand for these advanced monitoring solutions. According to the Centers for Disease Control and Prevention (CDC), over 27 million people in the U.S. are affected by asthma, with a notable prevalence among children. Asthma UK's estimates suggest there are over 300 million individuals suffering from this condition, and this figure is projected to exceed 400 million by 2025. The heightened awareness of the benefits of asthma monitoring devices, alongside technological advancements and increased focus from companies on developing smart inhalers-such as dry powder and metered dose inhalers-are essential factors fueling market growth. Key industry players are leveraging these innovations to improve asthma management and enhance the efficacy of prescribed treatments.

Restraints in the Global Intelligent Asthma Monitoring Devices Market

The Global Intelligent Asthma Monitoring Devices market faces significant restraints, particularly stemming from a lack of awareness regarding the effective utilization of smart inhalers and nebulizers. As pollution levels continue to rise globally, the incidence of asthma cases escalates, highlighting the urgent need for innovative and affordable monitoring devices that empower patients to actively engage in self-monitoring practices. However, the prevailing ignorance about how to properly use these advanced devices limits their adoption and effectiveness, ultimately hindering the overall growth of the intelligent asthma monitoring market. Addressing this knowledge gap is crucial for enhancing patient outcomes and market expansion.

Market Trends of the Global Intelligent Asthma Monitoring Devices Market

The Global Intelligent Asthma Monitoring Devices market is witnessing a significant upward trend, driven by the rising prevalence of asthma and respiratory conditions. Wearable technologies like the ADAMM smart patch exemplify this innovation, offering real-time monitoring of vital symptoms such as cough, respiration rate, and wheezing. These devices not only alert users with vibrations upon detecting deviations from individual norms but also enhance patient safety by sending notifications to caregivers. As healthcare increasingly adopts digital solutions for chronic disease management, the demand for such intelligent monitoring devices is expected to surge, heralding a transformative era in asthma care and patient autonomy.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Landscape
  • Case Studies
  • Technological Advancement
  • Trade Analysis

Global Intelligent Asthma Monitoring Devices Market Size by Product & CAGR (2025-2032)

  • Market Overview
  • Wearable Asthma Monitoring Devices
  • Smart Inhalers
  • Inhalers
  • Dry Powdered Inhalers (DPI's)
  • Metered Dose Inhalers (MDI's)
  • Nebulizers

Global Intelligent Asthma Monitoring Devices Market Size by End Use & CAGR (2025-2032)

  • Market Overview
  • Hospitals
  • Clinics
  • Home Use
  • Others

Global Intelligent Asthma Monitoring Devices Market Size & CAGR (2025-2032)

  • North America (Product, End Use)
    • US
    • Canada
  • Europe (Product, End Use)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, End Use)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, End Use)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, End Use)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Adherium Limited (New Zealand)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AstraZeneca plc (United Kingdom)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boehringer Ingelheim International GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cohero Health, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GlaxoSmithKline plc (United Kingdom)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Health Care Originals, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Koninklijke Philips N.V. (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teva Pharmaceutical Industries Ltd. (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vectura Group plc (United Kingdom)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Volansys Technologies Pvt. Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • 3M (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AEvice Health (Singapore)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Respiri Limited (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Quvium (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Findair (Poland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sensirion AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thorasys Thoracic Medical Systems Inc. (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vitalograph Ltd. (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zephyr Sleep Technologies (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제